Painkiller ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  2.8% 2.8% 2.8% 2.8% 2.8%  
Bankruptcy risk  0.0% 0.0% 9.0% 7.2% 6.7%  
Credit score (0-100)  0 0 26 33 34  
Credit rating  N/A N/A BB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -17.4 -14.6 -6.9  
EBITDA  0.0 0.0 -17.4 -14.6 -6.9  
EBIT  0.0 0.0 -17.4 -14.6 -6.9  
Pre-tax profit (PTP)  0.0 0.0 -17.4 -14.6 -8.1  
Net earnings  0.0 0.0 -13.6 -11.4 -15.1  
Pre-tax profit without non-rec. items  0.0 0.0 -17.4 -14.6 -8.1  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 26.4 15.0 -0.1  
Interest-bearing liabilities  0.0 0.0 459 504 624  
Balance sheet total (assets)  0.0 0.0 1,108 1,344 1,343  

Net Debt  0.0 0.0 458 502 616  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -17.4 -14.6 -6.9  
Gross profit growth  0.0% 0.0% 0.0% 16.1% 52.9%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 1,108 1,344 1,343  
Balance sheet change%  0.0% 0.0% 0.0% 21.2% -0.0%  
Added value  0.0 0.0 -17.4 -14.6 -6.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 1,103 231 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -1.6% -1.2% -0.5%  
ROI %  0.0% 0.0% -1.1% -1.0% -0.5%  
ROE %  0.0% 0.0% -51.4% -54.9% -2.2%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 2.4% 1.1% -0.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -2,631.3% -3,442.8% -8,966.8%  
Gearing %  0.0% 0.0% 1,737.3% 3,356.0% -743,266.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.2%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.3 0.4 0.2  
Current Ratio  0.0 0.0 0.3 0.4 0.2  
Cash and cash equivalent  0.0 0.0 1.3 2.2 8.7  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -9.9 -13.8 -28.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -17 -15 -7  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -17 -15 -7  
EBIT / employee  0 0 -17 -15 -7  
Net earnings / employee  0 0 -14 -11 -15